M. John et al., EXPRESSION OF EPIDERMAL GROWTH-FACTOR IN GESTATIONAL TROPHOBLASTIC DISEASE (GTD), Journal of experimental & clinical cancer research, 16(2), 1997, pp. 129-134
Gestational Trophoblastic Disease (GTD) is an abnormal condition of th
e placenta, the incidence of which is very high in the State of Kerala
, India. The biology of the disease is vague and methods to determine
the malignant potentialis limited, Placentae of normal (50) and molar
pregnancy (95) including 32 patients showing persistent disease were u
sed in this study. EGF expression was analyzed by immunohistochemistry
using monoclonal antibody to EGF and quantitated using isotope labell
ed antibody to EGF. EGF was expressed more strongly in molar placentae
in all gestational ages in comparison with normal placentae of simila
r gestational age, the expression being restricted mainly to first and
second trimesters in normal placentae. Moles with early presenting sy
mptoms (<12 weeks) were at a higher risk for developing persistent dis
ease. In conclusion, the immunohistochemical study shows high expressi
on of EGF in early normal placentae and moles linking its role to prol
iferative and differentiating activity of trophoblasts. Tumors with hi
stological diagnosis of invasive moles and choriocarcinoma showed very
strong binding of EGF and thus EGF has the potential of identifying h
igh risk lesions.